16.5 Octreotide is a long acting synthetic analogue of: A. Prolactin B. Growth hormone C. Somatostatin D. Gonadotropin releasing hormone

16.5 Octreotide is a long acting synthetic analogue of:
A. Prolactin
B. Growth hormone
C. Somatostatin
D. Gonadotropin releasing hormone
by

2 Answers

Answer :

C. Somatostatin
by

Answer :

D. All of the above
by

Related questions

16.8 Drugs that suppress growth hormone release in acromegaly include the following except: A. Bromocriptine B. Somatostatin C. Octreotide D. Nafarelin

Description : 16.8 Drugs that suppress growth hormone release in acromegaly include the following except: A. Bromocriptine B. Somatostatin C. Octreotide D. Nafarelin

Last Answer : D. Nafarelin

The following hypothalamic regulatory hormone is not a peptide: A. Growth hormone release inhibitory hormone B. Prolactin release inhibitory hormone C. Gonadotropin releasing hormone D. Corticotropin releasing hormone (

Description : The following hypothalamic regulatory hormone is not a peptide: A. Growth hormone release inhibitory hormone B. Prolactin release inhibitory hormone C. Gonadotropin releasing hormone D. Corticotropin releasing hormone (

Last Answer : B. Prolactin release inhibitory hormone

Growth hormone is released by (A) Somatostatin (B) Growth hormone releasing hormone (C) Prolactin release inhibiting hormone (D) Luteinizing releasing hormone

Description : Growth hormone is released by (A) Somatostatin (B) Growth hormone releasing hormone (C) Prolactin release inhibiting hormone (D) Luteinizing releasing hormone

Last Answer : Answer : B

16.15 The hypothalamic gonadotropin releasing hormone (GnRH) is: A. A single peptide B. A mixture of two distinct peptides FSH-RH and LH-RH C. A mixture of several peptides D. Dopamine

Description : 16.15 The hypothalamic gonadotropin releasing hormone (GnRH) is: A. A single peptide B. A mixture of two distinct peptides FSH-RH and LH-RH C. A mixture of several peptides D. Dopamine

Last Answer : A. A single peptide

When both ovaries are removed from rat then which hormone is decreased in blood? (a) Oxytocin (b) Prolactin (c) Estrogen (d) Gonadotropin releasing factor

Description : When both ovaries are removed from rat then which hormone is decreased in blood? (a) Oxytocin (b) Prolactin (c) Estrogen (d) Gonadotropin releasing factor

Last Answer : (c) Estrogen

Chlorpromazine therapy increases the secretion of the following hormone: A. Prolactin B. Gonadotropin C. Corticotropin D. Antidiuretic hormone

Description : Chlorpromazine therapy increases the secretion of the following hormone: A. Prolactin B. Gonadotropin C. Corticotropin D. Antidiuretic hormone

Last Answer : A. Prolactin

16.6 Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Description : 16.6 Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Last Answer : D. All of the above

Secretion of somatotrophin is promoted by (A) Somatomedin C (B) Somatostatin (C) Growth hormone releasing hormone (D) Hypoglycaemia

Description : Secretion of somatotrophin is promoted by (A) Somatomedin C (B) Somatostatin (C) Growth hormone releasing hormone (D) Hypoglycaemia

Last Answer : Answer : C

Gonadotropin releasing hormone (GnRH) stimulates the release of: a) ACTH. b) Growth hormone. c) Leutinising Hormone (LH). d) Thyroid stimulating hormone (TSH). e) Opiate peptides.

Description : Gonadotropin releasing hormone (GnRH) stimulates the release of: a) ACTH. b) Growth hormone. c) Leutinising Hormone (LH). d) Thyroid stimulating hormone (TSH). e) Opiate peptides.

Last Answer : c) Leutinising Hormone (LH).

6.4 Several actions of growth hormone are exerted through the elaboration of: A. Cyclic AMP B. Cyclic GMP C. Somatostatin D. Insulin like growth factor-1

Description : 6.4 Several actions of growth hormone are exerted through the elaboration of: A. Cyclic AMP B. Cyclic GMP C. Somatostatin D. Insulin like growth factor-1

Last Answer : D. Insulin like growth factor-1

Gonadotropin releasing hormone is formed by

Description : Gonadotropin releasing hormone is formed by

Last Answer : Gonadotropin releasing hormone is formed by A. Adenohypophysis B. Pars intermedia C. Neurohypophysis D. Hypothalamus.

In males, secretion of luteinising hormone is inhibited by (A) Gonadotropin releasing hormone (B) FSH (C) High blood level of testosterone (D) Inhibin

Description : In males, secretion of luteinising hormone is inhibited by (A) Gonadotropin releasing hormone (B) FSH (C) High blood level of testosterone (D) Inhibin

Last Answer : Answer : C

All the following statements about FSH are true except (A) It is a tropic hormone secreted by anterior pituitary (B) Its secretion is increased by gonadotropin releasing hormone (C) It acts on Sertoli cells (D) It increases the synthesis of testosterone

Description : All the following statements about FSH are true except (A) It is a tropic hormone secreted by anterior pituitary (B) Its secretion is increased by gonadotropin releasing hormone (C) It acts on Sertoli cells (D) It increases the synthesis of testosterone

Last Answer : Answer : D

The currently used injectable hormonal contraceptive contains: A. Long acting progestin B. Long acting estrogen C. Both long acting estrogen and progestin D. Chorionic gonadotropin

Description : The currently used injectable hormonal contraceptive contains: A. Long acting progestin B. Long acting estrogen C. Both long acting estrogen and progestin D. Chorionic gonadotropin

Last Answer : A. Long acting progestin

Secretion of prolactin is regulated by (A) Feedback inhibition (B) Prolactin releasing hormone (C) Prolactin release inhibiting hormone (D) All of these

Description : Secretion of prolactin is regulated by (A) Feedback inhibition (B) Prolactin releasing hormone (C) Prolactin release inhibiting hormone (D) All of these

Last Answer : Answer : C

6.2 Which hormone acts through a cytoplasmic receptor: A. Calcitriol B. Prolactin C. Vasopressin D. None of the abov

Description : 6.2 Which hormone acts through a cytoplasmic receptor: A. Calcitriol B. Prolactin C. Vasopressin D. None of the abov

Last Answer : A.Calcitol binds to cytoplasmic membrane and enhances the absorption of Calcium by increasing the calcium binding proteins-calbindin-D proteins.

16.17 Superactive GnRH agonists cause: A. Initial as well as sustained release of gonadotropins B. Initial inhibition followed by stimulation of gonadotropin release after 1-2 weeks C. Initial stimulation followed by inhibition of gonadotropin release after 1-2 weeks D. Initial as well as sustained inhibition of gonadotropin release

Description : 16.17 Superactive GnRH agonists cause: A. Initial as well as sustained release of gonadotropins B. Initial inhibition followed by stimulation of gonadotropin release after 1-2 weeks C. Initial ... release after 1-2 weeks D. Initial as well as sustained inhibition of gonadotropin release

Last Answer : C. Initial stimulation followed by inhibition of gonadotropin release after 1-2 weeks

Which of the following hormones is not a secretion product of human placenta? (a) Human chorionic gonadotropin (b) Prolactin (c) Estrogen (d) Progesterone

Description : Which of the following hormones is not a secretion product of human placenta? (a) Human chorionic gonadotropin (b) Prolactin (c) Estrogen (d) Progesterone

Last Answer : (b) Prolactin

16.11 Bromocriptine causes the following: A. Prolactin release B. Vomiting C. Uterine contraction D. Impotence

Description : 16.11 Bromocriptine causes the following: A. Prolactin release B. Vomiting C. Uterine contraction D. Impotence

Last Answer : B. Vomiting

Choose the correct statement about drotaverine: A. It is a smooth muscle antispasmodic acting by non-anticholinergic mechanisms B. It is a papaverine congener used in peripheral vascular diseases C. It is a synthetic atropine substitute used to control diarrhoea D. It is a M1/M3 selective antagonist used for spastic constipation

Description : Choose the correct statement about drotaverine: A. It is a smooth muscle antispasmodic acting by non-anticholinergic mechanisms B. It is a papaverine congener used in peripheral vascular diseases C. It ... used to control diarrhoea D. It is a M1/M3 selective antagonist used for spastic constipation

Last Answer : A. It is a smooth muscle antispasmodic acting by non-anticholinergic mechanisms

3- Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Description : 3- Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Last Answer : 3- Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Secretion of growth hormone is inhibited by (A) Somatomedin C (B) Somatostatin (C) Feedback inhibition(D) All of these

Description : Secretion of growth hormone is inhibited by (A) Somatomedin C (B) Somatostatin (C) Feedback inhibition(D) All of these

Last Answer : Answer : B

Which one of the following is not liberated by the adenohypophysis? (A) Growth hormone (B) TSH (C) ACTH (D) Gonadotropin

Description : Which one of the following is not liberated by the adenohypophysis? (A) Growth hormone (B) TSH (C) ACTH (D) Gonadotropin

Last Answer : Answer : D

16.3 Actions of growth hormone include the following except: A. Increased protein synthesis B. Increased fat utilization C. Increased carbohydrate utilization D. Glucose intolerance

Description : 16.3 Actions of growth hormone include the following except: A. Increased protein synthesis B. Increased fat utilization C. Increased carbohydrate utilization D. Glucose intolerance

Last Answer : C. Increased carbohydrate utilization

Select the correct matching of a hormone, its source and function. Hormone Source Function (a) Vasopressin Posterior Increases loss pituitary of water through urine (b) Norepine- Adrenal Increases heart phrine medulla beat, rate of respiration and alterness (c) Glucagon Beta-cells Stimulates of Islets of glycogenolysis Langerhans (d) Prolactin Posterior Regulates growth pituitary of mammary glands and milk formation in females

Description : Select the correct matching of a hormone, its source and function. Hormone Source Function (a) Vasopressin Posterior Increases loss pituitary of water through urine (b) Norepine- Adrenal ... (d) Prolactin Posterior Regulates growth pituitary of mammary glands and milk formation in females

Last Answer : (b) Norepine- Adrenal Increases heart phrine medulla beat, rate of respiration and alterness

The hormone causing growth of the endometrium (pron: en-doe-me-tree-um) is: a) androgen (pron: ann-drah-jen) b) leutenizing hormone (pron: lew-ten-I-zing) c) estrogen d) prolactin

Description : The hormone causing growth of the endometrium (pron: en-doe-me-tree-um) is: a) androgen (pron: ann-drah-jen) b) leutenizing hormone (pron: lew-ten-I-zing) c) estrogen d) prolactin 

Last Answer : ANSWER: C -- estrogen 

A synthetic nucleotide analogue, used in the chemotherapy of cancer and viral infections is (A) Arabinosyl cytosine (B) 4-Hydroxypyrazolopyrimidine (C) 6-Mercaptopurine (D) 6-Thioguanine

Description : A synthetic nucleotide analogue, used in the chemotherapy of cancer and viral infections is (A) Arabinosyl cytosine (B) 4-Hydroxypyrazolopyrimidine (C) 6-Mercaptopurine (D) 6-Thioguanine

Last Answer : Answer : A

A synthetic nucleotide analogue, 4-hydroxypyrazolopyrimidine is used in the treatment of (A) Acute nephritis (B) Gout (C) Cystic fibrosis of lung (D) Multiple myeloma

Description : A synthetic nucleotide analogue, 4-hydroxypyrazolopyrimidine is used in the treatment of (A) Acute nephritis (B) Gout (C) Cystic fibrosis of lung (D) Multiple myeloma

Last Answer : Answer : B

A synthetic nucleotide analogue, used in organ transplantation as a suppressor of immunologic rejection of grafts is (A) Theophylline (B) Cytarabine (C) 4-Hydroxypyrazolopyrimidine (D) 6-Mercaptopurine

Description : A synthetic nucleotide analogue, used in organ transplantation as a suppressor of immunologic rejection of grafts is (A) Theophylline (B) Cytarabine (C) 4-Hydroxypyrazolopyrimidine (D) 6-Mercaptopurine

Last Answer : Answer : D

Choose the correct statement about latanoprost: A. It is a PGF2α derivative used in glaucoma B. It is a selective α1 blocker used in benign hypertrophy of prostate C. It is a 5-α-reductase inhibitor used to reduce the size of enlarged prostate gland D. It is a PGE2 analogue used intravaginally for cervical priming

Description : Choose the correct statement about latanoprost: A. It is a PGF2α derivative used in glaucoma B. It is a selective α1 blocker used in benign hypertrophy of prostate C. It is a 5-α- ... reduce the size of enlarged prostate gland D. It is a PGE2 analogue used intravaginally for cervical priming

Last Answer : A. It is a PGF2α derivative used in glaucoma

Choose the correct statement about latanoprost: A. It is a PGF2α derivative used in glaucoma B. It is a selective α1 blocker used in benign hypertrophy of prostate C. It is a 5-α-reductase inhibitor used to reduce the size of enlarged prostate gland D. It is a PGE2 analogue used intravaginally for cervical priming

Description : Choose the correct statement about latanoprost: A. It is a PGF2α derivative used in glaucoma B. It is a selective α1 blocker used in benign hypertrophy of prostate C. It is a 5-α- ... reduce the size of enlarged prostate gland D. It is a PGE2 analogue used intravaginally for cervical priming

Last Answer : A. It is a PGF2α derivative used in glaucoma

Glucagon release from pancreas is stimulated by: A. High blood glucose level B. Insulin C. Somatostatin D. Adrenaline

Description : Glucagon release from pancreas is stimulated by: A. High blood glucose level B. Insulin C. Somatostatin D. Adrenaline

Last Answer : D. Adrenaline

Indications of somatostatin include: A. Macroprolactinoma B. Zollinger Ellison syndrome C. Bleeding esophageal varices D. Steatorrhoea

Description : Indications of somatostatin include: A. Macroprolactinoma B. Zollinger Ellison syndrome C. Bleeding esophageal varices D. Steatorrhoea

Last Answer : C. Bleeding esophageal varices

Superactive GnRH agonists cause: A. Initial as well as sustained release of gonadotropins B. Initial inhibition followed by stimulation of gonadotropin release after 1-2 weeks C. Initial stimulation followed by inhibition of gonadotropin release after 1-2 weeks D. Initial as well as sustained inhibition of gonadotropin release

Description : Superactive GnRH agonists cause: A. Initial as well as sustained release of gonadotropins B. Initial inhibition followed by stimulation of gonadotropin release after 1-2 weeks C. Initial stimulation ... release after 1-2 weeks D. Initial as well as sustained inhibition of gonadotropin release

Last Answer : C. Initial stimulation followed by inhibition of gonadotropin release after 1-2 weeks

The hormone somatostatin is resposible for inhibiting the motility and absobtion in the digestive tract. It also inhibits the release of insuline and

Description : The hormone somatostatin is resposible for inhibiting the motility and absobtion in the digestive tract. It also inhibits the release of insuline and

Last Answer : The hormone somatostatin is resposible for inhibiting the motility and absobtion in the digestive tract. It also ... Alph B. Beta C. Delta D. F cells

Potassium metabolism is regulated by the hormone: (A) Aldosterone (B) PTH (C) Somatostatin (D) Estrogen

Description : Potassium metabolism is regulated by the hormone: (A) Aldosterone (B) PTH (C) Somatostatin (D) Estrogen

Last Answer : Answer : A

The metabolism of sodium is regulated by the hormone: (A) Insulin (B) Aldosterone (C) PTH (D) Somatostatin

Description : The metabolism of sodium is regulated by the hormone: (A) Insulin (B) Aldosterone (C) PTH (D) Somatostatin

Last Answer : Answer : B

Which of one of the following is released by hypothalamus? (A) Somatostatin (B) Somatotropic hormone (C) Somato medin C (D) Luteinising hormone

Description : Which of one of the following is released by hypothalamus? (A) Somatostatin (B) Somatotropic hormone (C) Somato medin C (D) Luteinising hormone

Last Answer : Answer : A

Placental hormone called chorionic gonadotropin (HCG) which stimulates secretion of progesterone by the ovary during pregnancy is

Description : Placental hormone called chorionic gonadotropin (HCG) which stimulates secretion of progesterone by the ovary during pregnancy is

Last Answer : Placental hormone called chorionic gonadotropin (HCG) which stimulates secretion of progesterone by the ovary during ... amine D. Both (1) and (2)

Placenta secretes all of the following except (A) FSH (B) Progesterone (C) Estrogen (D) Chorionic gonadotropin HORMONE METABOLISM 225

Description : Placenta secretes all of the following except (A) FSH (B) Progesterone (C) Estrogen (D) Chorionic gonadotropin HORMONE METABOLISM 225

Last Answer : Answer : A

A hormone used for detection of pregnancy is (A) Estrogen (B) Progesterone (C) Oxytocin (D) Chorionic gonadotropin

Description : A hormone used for detection of pregnancy is (A) Estrogen (B) Progesterone (C) Oxytocin (D) Chorionic gonadotropin

Last Answer : Answer : D

The hormone measured in urine to test pregnancy is (A) Anterior pituitary luteinizing hormone (B) Androgen (C) Progesterone (D) Choroinic gonadotropin

Description : The hormone measured in urine to test pregnancy is (A) Anterior pituitary luteinizing hormone (B) Androgen (C) Progesterone (D) Choroinic gonadotropin

Last Answer : Answer : D

Angiotensin III is equipotent to angiotensin II in: A. Releasing aldosterone from adrenal cortex B. Promoting Na+ and water reabsorption by direct intrarenal action C. Causing vasoconstriction D. Contracting intestinal smooth muscle

Description : Angiotensin III is equipotent to angiotensin II in: A. Releasing aldosterone from adrenal cortex B. Promoting Na+ and water reabsorption by direct intrarenal action C. Causing vasoconstriction D. Contracting intestinal smooth muscle

Last Answer : A. Releasing aldosterone from adrenal cortex

Angiotensin II causes rise in blood pressure by: A. Direct vasoconstriction B. Releasing adrenaline from adrenal medulla C. Increasing central sympathetic tone D. All of the above

Description : Angiotensin II causes rise in blood pressure by: A. Direct vasoconstriction B. Releasing adrenaline from adrenal medulla C. Increasing central sympathetic tone D. All of the above

Last Answer : D. All of the above

Guargum limits post-prandial glycaemia by: A. Inhibiting intestinal brush border α-glucosidases B. Slowing carbohydrate absorption from intestine C. Releasing incretins from the intestine D. Promoting uptake of glucose into skeletal muscles

Description : Guargum limits post-prandial glycaemia by: A. Inhibiting intestinal brush border α-glucosidases B. Slowing carbohydrate absorption from intestine C. Releasing incretins from the intestine D. Promoting uptake of glucose into skeletal muscles

Last Answer : B. Slowing carbohydrate absorption from intestin

Metformin acts by: A. Releasing insulin from pancreas B. Suppressing gluconeogenesis and glucose output from liver

Description : Metformin acts by: A. Releasing insulin from pancreas B. Suppressing gluconeogenesis and glucose output from liver

Last Answer : B. Suppressing gluconeogenesis and glucose output from liver

6.9 For therapeutic use, growth hormone is obtained from: A. Recombinant DNA technique B. Human cadaver pituitaries C. Porcine pituitaries D. Chemical synthesis

Description : 6.9 For therapeutic use, growth hormone is obtained from: A. Recombinant DNA technique B. Human cadaver pituitaries C. Porcine pituitaries D. Chemical synthesis

Last Answer : A. Recombinant DNA technique

16.20 Adrenocorticotropic hormone is primarily used for: A. Treatment of Addison’s disease B. Treatment of congenital adrenal hyperplasia C. Treatment of autoimmune diseases D. Diagnosis of pituitary-adrenal axis disorders

Description : 16.20 Adrenocorticotropic hormone is primarily used for: A. Treatment of Addison’s disease B. Treatment of congenital adrenal hyperplasia C. Treatment of autoimmune diseases D. Diagnosis of pituitary-adrenal axis disorders

Last Answer : D. Diagnosis of pituitary-adrenal axis disorders

Effect of prolactin hormone is on

Description : Effect of prolactin hormone is on

Last Answer : Effect of prolactin hormone is on A. Liver B. Parcreas C. Mammary glands D. Bones

Prolactin release inhibiting hormone is believed to be (A) Serotonin (B) Norepinephrine (C) Dopanine (D) Acetyl choline

Description : Prolactin release inhibiting hormone is believed to be (A) Serotonin (B) Norepinephrine (C) Dopanine (D) Acetyl choline

Last Answer : Answer : C